Nathan Caffo

Insider Reports History

Location
Burlingame, CA
Signature
/s/ John Canepa, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by Nathan Caffo:

Company Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Chief Business Officer Common Stock 6,000 $5,400 $0.9000 29 Jul 2021 Direct

Insider Reports Filed by Nathan Caffo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CADL Candel Therapeutics, Inc. 29 Jul 2021 1 +$48,000 4 Chief Business Officer 02 Aug 2021, 20:02
CADL Candel Therapeutics, Inc. 26 Jul 2021 0 $0 3 Chief Business Officer 26 Jul 2021, 21:18